1. Golden Rice is an effective source of vitamin A
- Author
-
Tang, Guangwen, Qin, Jian, Dolnikowski, Gregory G., Russell, Robert M., and Grusak, Michael A.
- Subjects
Beta carotene -- Health aspects ,Beta carotene -- Research ,Genetically modified crops -- Nutritional aspects ,Genetically modified crops -- Research ,Vitamin A -- Health aspects ,Vitamin A -- Research ,Food/cooking/nutrition ,Health - Abstract
Background: Genetically engineered 'Golden Rice' contains up to 35 [micro]g [beta]-carotene per gram of rice. It is important to determine the vitamin A equivalency of Golden Rice [beta]-carotene to project the potential effect of this biofortified grain in rice-consuming populations that commonly exhibit low vitamin A status. Objective: The objective was to determine the vitamin A value of intrinsically labeled dietary Golden Rice in humans. Design: Golden Rice plants were grown hydroponically with heavy water (deuterium oxide) to generate deuterium-labeled [[sup.2]H][beta]-carotene in the rice grains. Golden Rice servings of 65-98 g (130-200 g cooked rice) containing 0.99-1.53 mg [beta]-carotene were fed to 5 healthy adult volunteers (3 women and 2 men) with 10 g butter. A reference dose of [[sup.13][C.sub.10]]retinyl acetate (0.4-1.0 mg) in oil was given to each volunteer 1 wk before ingestion of the Golden Rice dose. Blood samples were collected over 36 d. Results: Our results showed that the mean ([+ or -]SD) area under the curve for the total serum response to [[sup.2]H]retinol was 39.9 [+ or -] 20.7 [micro]g x d after the Golden Rice dose. Compared with that of the [[sup.13][C.sub.10]]retinyl acetate reference dose (84.7 [+ or -] 34.6 [micro]g x d), Golden Rice [beta]-carotene provided 0.244).94 mg retinol. Thus, the conversion factor of Golden Rice [beta]-carotene to retinol is 3.8 [+ or -] 1.7 to 1 with a range of 1.9-6.4 to 1 by weight, or 2.0 [+ or -] 0.9 to 1 with a range of 1.0-3.4 to 1 by moles. Conclusion: [beta]-Carotene derived from Golden Rice is effectively converted to vitamin A in humans. This trial was registered at clinicaltrials.gov as NCT00680355.
- Published
- 2009